TONIX PHARMACEUTICALS HOLDING CORP. Operating Cash Flow
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Operating Cash Flow of -$84.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$42.24M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$42.32M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$39.65M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$28.78M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) operating activities for fiscal 2025 was -$99.84M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) operating activities for fiscal 2024 was -$60.92M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) operating activities for fiscal 2023 was -$102.00M.
- TONIX PHARMACEUTICALS HOLDING CORP. net cash provided by (used in) operating activities for fiscal 2022 was -$98.05M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 43 month | Net Cash Provided by (Used in) Operating Activities 46 month | Net Cash Provided by (Used in) Operating Activities 55 month | Net Cash Provided by (Used in) Operating Activities 58 month | Net Cash Provided by (Used in) Operating Activities 61 month | Net Cash Provided by (Used in) Operating Activities 64 month | Net Cash Provided by (Used in) Operating Activities 67 month | Net Cash Provided by (Used in) Operating Activities 70 month | Net Cash Provided by (Used in) Operating Activities 73 month | Net Cash Provided by (Used in) Operating Activities 76 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$42.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$84.56M 10-Q · filed 2026-08-10 | -$124.21M derived: sum of 3 quarters · filed 2026-08-10 | -$152.99M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||
| 2026-03-31 | -$42.32M 10-Q · filed 2026-05-11 | -$81.97M derived: sum of 2 quarters · filed 2026-05-11 | -$110.75M derived: sum of 3 quarters · filed 2026-05-11 | -$125.58M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||
| 2025-12-31 | -$39.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$68.43M derived: sum of 2 quarters · filed 2026-03-12 | -$83.27M derived: sum of 3 quarters · filed 2026-08-10 | -$99.84M 10-K · filed 2026-03-12 | |||||||||||||
| 2025-09-30 | -$28.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$43.62M derived: sum of 2 quarters · filed 2026-08-10 | -$60.19M 10-Q · filed 2025-11-10 | -$74.82M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||
| 2025-06-30 | -$14.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$31.41M 10-Q · filed 2026-08-10 | -$46.04M derived: sum of 3 quarters · filed 2026-08-10 | -$64.84M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||
| 2025-03-31 | -$16.58M 10-Q · filed 2026-05-11 | -$31.21M derived: sum of 2 quarters · filed 2026-05-11 | -$50.01M derived: sum of 3 quarters · filed 2026-05-11 | -$59.93M derived: sum of 4 quarters · filed 2026-05-11 | |||||||||||||
| 2024-12-31 | -$14.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$33.43M derived: sum of 2 quarters · filed 2026-03-12 | -$43.35M derived: sum of 3 quarters · filed 2026-03-12 | -$60.92M 10-K · filed 2026-03-12 | |||||||||||||
| 2024-09-30 | -$18.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$28.72M derived: sum of 2 quarters · filed 2025-11-10 | -$46.30M 10-Q · filed 2025-11-10 | -$68.64M derived: sum of 4 quarters · filed 2025-11-10 | |||||||||||||
| 2024-06-30 | -$9.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$27.49M 10-Q · filed 2025-08-11 | -$49.83M derived: sum of 3 quarters · filed 2025-08-11 | -$73.22M derived: sum of 4 quarters · filed 2025-08-11 | |||||||||||||
| 2024-03-31 | -$17.57M 10-Q · filed 2025-05-12 | -$39.91M derived: sum of 2 quarters · filed 2025-05-12 | -$63.30M derived: sum of 3 quarters · filed 2025-05-12 | -$86.67M derived: sum of 4 quarters · filed 2025-05-12 | |||||||||||||
| 2023-12-31 | -$22.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$45.73M derived: sum of 2 quarters · filed 2025-03-18 | -$69.09M derived: sum of 3 quarters · filed 2025-03-18 | -$102.00M 10-K · filed 2025-03-18 | |||||||||||||
| 2023-09-30 | -$23.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$46.75M derived: sum of 2 quarters · filed 2024-11-12 | -$79.66M 10-Q · filed 2024-11-12 | -$101.96M derived: sum of 4 quarters · filed 2024-11-12 | |||||||||||||
| 2023-06-30 | -$23.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | -$56.28M 10-Q · filed 2024-08-16 | -$78.58M derived: sum of 3 quarters · filed 2024-08-16 | -$102.11M derived: sum of 4 quarters · filed 2024-08-16 | |||||||||||||
| 2023-03-31 | -$32.91M 10-Q · filed 2024-05-13 | -$55.21M derived: sum of 2 quarters · filed 2024-05-13 | -$78.75M derived: sum of 3 quarters · filed 2024-05-13 | -$99.92M derived: sum of 4 quarters · filed 2024-05-13 | |||||||||||||
| 2022-12-31 | -$22.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$45.84M derived: sum of 2 quarters · filed 2024-04-01 | -$67.01M derived: sum of 3 quarters · filed 2024-04-01 | -$98.05M 10-K · filed 2024-04-01 | |||||||||||||
| 2022-09-30 | -$23.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$44.71M derived: sum of 2 quarters · filed 2023-11-09 | -$75.75M 10-Q · filed 2023-11-09 | -$98.20M derived: sum of 4 quarters · filed 2023-11-09 | |||||||||||||
| 2022-06-30 | -$21.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$52.22M 10-Q · filed 2023-08-10 | -$74.66M derived: sum of 3 quarters · filed 2023-08-10 | -$87.61M derived: sum of 4 quarters · filed 2023-08-10 | |||||||||||||
| 2022-03-31 | -$31.05M 10-Q · filed 2023-05-08 | -$53.49M derived: sum of 2 quarters · filed 2023-05-08 | -$66.44M derived: sum of 3 quarters · filed 2023-05-08 | -$85.55M derived: sum of 4 quarters · filed 2023-05-08 | |||||||||||||
| 2021-12-31 | -$22.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$35.39M derived: sum of 2 quarters · filed 2023-03-13 | -$54.50M derived: sum of 3 quarters · filed 2023-03-13 | -$75.56M 10-K · filed 2023-03-13 | |||||||||||||
| 2021-09-30 | -$12.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$32.05M derived: sum of 2 quarters · filed 2022-11-07 | -$53.11M 10-Q · filed 2022-11-07 | -$67.03M derived: sum of 4 quarters · filed 2022-11-07 | |||||||||||||
| 2021-06-30 | -$19.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$40.17M 10-Q · filed 2022-08-08 | -$54.08M derived: sum of 3 quarters · filed 2022-08-08 | -$69.36M derived: sum of 4 quarters · filed 2022-08-08 | |||||||||||||
| 2021-03-31 | -$21.06M 10-Q · filed 2022-05-09 | -$34.97M derived: sum of 2 quarters · filed 2022-05-09 | -$50.26M derived: sum of 3 quarters · filed 2022-05-09 | -$60.30M derived: sum of 4 quarters · filed 2022-05-09 | |||||||||||||
| 2020-12-31 | -$13.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -$29.20M derived: sum of 2 quarters · filed 2022-03-14 | -$39.24M derived: sum of 3 quarters · filed 2022-03-14 | -$48.57M 10-K · filed 2022-03-14 | |||||||||||||
| 2020-09-30 | -$15.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$25.33M derived: sum of 2 quarters · filed 2021-11-08 | -$34.65M 10-Q · filed 2021-11-08 | -$41.34M derived: sum of 4 quarters · filed 2021-11-08 | |||||||||||||
| 2020-06-30 | -$10.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$19.37M 10-Q · filed 2021-08-09 | -$26.05M derived: sum of 3 quarters · filed 2021-08-09 | -$32.70M derived: sum of 4 quarters · filed 2021-08-09 | |||||||||||||
| 2020-03-31 | -$9.33M 10-Q · filed 2021-05-10 | -$16.01M derived: sum of 2 quarters · filed 2021-05-10 | -$22.65M derived: sum of 3 quarters · filed 2021-05-10 | -$27.37M derived: sum of 4 quarters · filed 2021-05-10 | |||||||||||||
| 2019-12-31 | -$6.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$13.33M derived: sum of 2 quarters · filed 2021-03-15 | -$18.04M derived: sum of 3 quarters · filed 2021-03-15 | -$26.68M 10-K · filed 2021-03-15 | |||||||||||||
| 2019-09-30 | -$6.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$11.36M derived: sum of 2 quarters · filed 2020-11-09 | -$20.00M 10-Q · filed 2020-11-09 | -$19.97M 10-Q · filed 2019-11-08 | -$26.82M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||
| 2019-06-30 | -$4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$13.36M 10-Q · filed 2020-08-10 | -$20.18M derived: sum of 3 quarters · filed 2020-08-10 | -$25.07M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||||||
| 2019-03-31 | -$8.64M 10-Q · filed 2020-05-12 | -$8.64M 10-Q · filed 2019-05-13 | -$15.47M derived: sum of 2 quarters · filed 2020-05-12 | -$20.36M derived: sum of 3 quarters · filed 2020-05-12 | -$25.84M derived: sum of 4 quarters · filed 2020-05-12 | ||||||||||||
| 2018-12-31 | -$6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | -$11.71M derived: sum of 2 quarters · filed 2020-03-24 | -$17.20M derived: sum of 3 quarters · filed 2020-03-24 | -$23.97M 10-K · filed 2020-03-24 | |||||||||||||
| 2018-09-30 | -$4.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$10.38M derived: sum of 2 quarters · filed 2019-11-08 | -$17.15M 10-Q · filed 2019-11-08 | -$22.07M derived: sum of 4 quarters · filed 2019-11-08 | |||||||||||||
| 2018-06-30 | -$5.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$12.26M 10-Q · filed 2019-08-12 | -$17.18M derived: sum of 3 quarters · filed 2019-08-12 | -$22.23M derived: sum of 4 quarters · filed 2019-08-12 | |||||||||||||
| 2018-03-31 | -$6.77M 10-Q · filed 2019-05-13 | -$11.70M derived: sum of 2 quarters · filed 2019-05-13 | -$16.75M derived: sum of 3 quarters · filed 2019-05-13 | -$21.11M derived: sum of 4 quarters · filed 2019-05-13 | |||||||||||||
| 2017-12-31 | -$4.93M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$9.97M derived: sum of 2 quarters · filed 2019-03-18 | -$14.33M derived: sum of 3 quarters · filed 2019-03-18 | -$19.13M 10-K · filed 2019-03-18 | |||||||||||||
| 2017-09-30 | -$5.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$9.41M derived: sum of 2 quarters · filed 2018-11-09 | -$14.20M 10-Q · filed 2018-11-09 | -$19.64M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||||||
| 2017-06-30 | -$4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$9.15M 10-Q · filed 2018-08-13 | -$14.60M derived: sum of 3 quarters · filed 2018-08-13 | ||||||||||||||
| 2017-03-31 | -$4.79M 10-Q · filed 2018-05-11 | -$10.23M derived: sum of 2 quarters · filed 2018-05-11 | |||||||||||||||
| 2016-12-31 | -$5.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$37.31M 10-K · filed 2018-03-09 | |||||||||||||||
| 2016-09-30 | -$31.87M 10-Q · filed 2017-11-06 | ||||||||||||||||
| 2013-09-30 | -$2.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$3.62M derived: sum of 2 quarters · filed 2013-11-13 | -$4.99M 10-Q · filed 2013-11-13 | -$6.49M derived: sum of 4 quarters · filed 2013-11-22 | -$15.19M 10-Q · filed 2013-11-13 | ||||||||||||
| 2013-06-30 | -$761.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$2.12M 10-Q · filed 2013-08-14 | -$3.63M derived: sum of 3 quarters · filed 2013-11-22 | -$4.93M derived: sum of 4 quarters · filed 2013-11-22 | -$12.33M 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | -$1.36M 10-Q · filed 2013-05-07 | -$2.87M derived: sum of 2 quarters · filed 2013-11-22 | -$4.17M derived: sum of 3 quarters · filed 2013-11-22 | -$5.30M derived: sum of 4 quarters · filed 2013-11-22 | -$11.57M 10-Q · filed 2013-05-07 | ||||||||||||
| 2012-12-31 | -$1.51M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-22 | -$2.81M derived: sum of 2 quarters · filed 2013-11-22 | -$3.94M derived: sum of 3 quarters · filed 2013-11-22 | -$5.71M 10-K/A · filed 2013-11-22 | -$10.20M 10-K/A · filed 2013-11-22 | ||||||||||||
| 2012-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$2.43M derived: sum of 2 quarters · filed 2013-11-13 | -$4.21M 10-Q · filed 2013-11-13 | -$5.67M derived: sum of 4 quarters · filed 2013-11-22 | -$8.70M 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | -$1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$2.91M 10-Q · filed 2013-08-14 | -$4.37M derived: sum of 3 quarters · filed 2013-11-22 | -$4.93M derived: sum of 4 quarters · filed 2013-11-22 | -$7.40M 10-Q · filed 2012-08-13 | ||||||||||||
| 2012-03-31 | -$1.78M 10-Q · filed 2013-05-07 | -$3.24M derived: sum of 2 quarters · filed 2013-11-22 | -$3.80M derived: sum of 3 quarters · filed 2013-11-22 | -$4.03M derived: sum of 4 quarters · filed 2013-11-22 | -$6.27M 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | -$1.47M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-22 | -$2.03M derived: sum of 2 quarters · filed 2013-11-22 | -$2.26M derived: sum of 3 quarters · filed 2013-11-22 | -$2.64M 10-K/A · filed 2013-11-22 | -$4.49M 10-K · filed 2012-03-30 | ||||||||||||
| 2011-09-30 | -$558.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$789.92K derived: sum of 2 quarters · filed 2012-11-14 | -$1.17M 10-Q · filed 2012-11-14 | -$4.42K 10-Q · filed 2011-10-07 | -$2.39M derived: sum of 4 quarters · filed 2012-11-14 | -$74.80K 10-Q · filed 2011-10-07 | |||||||||||
| 2011-06-30 | -$231.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | -$612.36K 10-Q · filed 2012-08-13 | -$3.88K 10-Q · filed 2011-08-15 | -$1.84M derived: sum of 3 quarters · filed 2012-08-13 | -$1.84M derived: sum of 4 quarters · filed 2012-08-13 | -$74.25K 10-Q · filed 2011-08-15 | |||||||||||
| 2011-03-31 | -$380.95K 10-Q · filed 2012-05-15 | -$1.60M derived: sum of 2 quarters · filed 2012-05-15 | -$1.61M derived: sum of 3 quarters · filed 2012-05-15 | ||||||||||||||
| 2010-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$1.22M derived: sum of 2 quarters · filed 2012-03-30 | -$1.23M 10-K · filed 2012-03-30 | ||||||||||||||
| 2010-09-30 | -$2.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-07 | -$10.53K 10-Q · filed 2011-10-07 | |||||||||||||||
| 2010-06-30 | -$8.48K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |